|
|
Ani Pharmaceuticals Inc (ANIP) |
|
|
|
Ani Pharmaceuticals Inc's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
ANIP Annual Income from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Income from Cont. Operations Change |
- |
- |
- |
- |
-60.67 % |
Annual Income from Cont. Operations (in millions $) |
$18.78 |
$-47.90 |
$-42.60 |
$-22.55 |
$6.09 |
Annual Income from Cont. Operations Growth
Comment |
In the fiscal year ended 2023, company achieved Annual Income from Cont. Operations of $18.78 millions compare to loss from Cont. Operations of $-47.90 millions realized a year before.
Ani Pharmaceuticals Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2023 Annual Income from Cont. Operations | Viatris Inc | -97.37 % | $ 54.700 millions | Revvity Inc | -64.99 % | $ 179.503 millions | Envista Holdings Corporation | | | |